Literature DB >> 8956781

Selective uptake of boronated low-density lipoprotein in melanoma xenografts achieved by diet supplementation.

Y Setiawan1, D E Moore, B J Allen.   

Abstract

The lipid core of human plasma low-density lipoprotein (LDL) was extracted using hexane and the LDL reconstituted with the addition of n-octyl-carborane. Biodistribution studies of the boronated LDL were performed in BALB/c mice bearing subcutaneous Harding-Passey melanoma xenografts. When diet supplementation with coconut oil and cholesterol for 21 days and regular dosing with hydrocortisone for 7 days before the studies was used to down-regulate the liver LDL receptors and the adrenal receptors, respectively, the tumour-blood boron concentration ratio of 5:1 was achieved.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8956781      PMCID: PMC2077221          DOI: 10.1038/bjc.1996.618

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells.

Authors:  Y K Ho; R G Smith; M S Brown; J L Goldstein
Journal:  Blood       Date:  1978-12       Impact factor: 22.113

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  New tumor localizers: advances in the use of low density lipoproteins (LDL).

Authors:  S B Kahl; J C Callaway
Journal:  Strahlenther Onkol       Date:  1989 Feb-Mar       Impact factor: 3.621

5.  Determination of boron in biological tissues by inductively coupled plasma atomic emission spectrometry.

Authors:  S R Tamat; D E Moore; B J Allen
Journal:  Anal Chem       Date:  1987-09-01       Impact factor: 6.986

6.  Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice.

Authors:  M Masquelier; S Vitols; C Peterson
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

7.  Fourier transform infrared (FTIR) spectrometry for the assay of polyhedral boron compounds in plasma and pharmaceutical formulations.

Authors:  Y Setiawan; T Rise; D E Moore
Journal:  Pharm Res       Date:  1994-05       Impact factor: 4.200

Review 8.  Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells.

Authors:  R A Firestone
Journal:  Bioconjug Chem       Date:  1994 Mar-Apr       Impact factor: 4.774

9.  Biological efficacy of boronated low-density lipoprotein for boron neutron capture therapy as measured in cell culture.

Authors:  B H Laster; S B Kahl; E A Popenoe; D W Pate; R G Fairchild
Journal:  Cancer Res       Date:  1991-09-01       Impact factor: 12.701

10.  Biodistribution study of 99mTc-labeled LDL in B16-melanoma-bearing mice. Visualization of a preferential uptake by the tumor.

Authors:  E Ponty; G Favre; R Benaniba; A Boneu; H Lucot; M Carton; G Soula
Journal:  Int J Cancer       Date:  1993-05-28       Impact factor: 7.396

View more
  2 in total

1.  Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy.

Authors:  Jennifer J Sudimack; Dianne Adams; Joan Rotaru; Supriya Shukla; Junhua Yan; Masaru Sekido; Rolf F Barth; Werner Tjarks; Robert J Lee
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

Review 2.  Ligand liposomes and boron neutron capture therapy.

Authors:  Jörgen Carlsson; Erika Bohl Kullberg; Jacek Capala; Stefan Sjöberg; Katarina Edwards; Lars Gedda
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.